Deversify Health AB (OSTO:DEV) EBIT per Share : kr-0.04 (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Deversify Health AB EBIT per Share?

Deversify Health AB's EBIT per Share for the three months ended in Jun. 2024 was kr-0.02. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was kr-0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Deversify Health AB's EBIT per Share or its related term are showing as below:

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Deversify Health AB was -256.00% per year. The lowest was -256.00% per year. And the median was -256.00% per year.

OSTO:DEV's 3-Year EBIT Growth Rate is not ranked ^*
in the Software industry.
Industry Median: 11.1
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Deversify Health AB's EBIT for the three months ended in Jun. 2024 was kr-1.13 Mil.

Deversify Health AB EBIT per Share Historical Data

The historical data trend for Deversify Health AB's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deversify Health AB EBIT per Share Chart

Deversify Health AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

-0.01

0.03

-0.40

-0.36

-0.29

Deversify Health AB Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24
EBIT per Share	Get a 7-Day Free Trial										-	-0.06	-	-0.03	-0.02

Deversify Health AB EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Deversify Health AB's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-21.008	/	72.839
=	-0.29

Deversify Health AB's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.127	/	72.928
=	-0.02

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.04

Deversify Health AB (OSTO:DEV) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Deversify Health AB EBIT per Share Related Terms

Thank you for viewing the detailed overview of Deversify Health AB's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Deversify Health AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Deversify Health AB (OSTO:DEV) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ulls vag 29C, Uppsala, SWE, 756 51

Website

https://www.deversify.com

Deversify Health AB offers health tech solutions for consumers. The company develops and commercializes mobile electronic devices and apps to monitor biomarkers for individualized health, specializing in breathalyzers. The company also develops and provides education services regarding metabolic health and personalized nutrition.